Invest A/S Lundbeckfond is of IO Biotech, Inc.. Currently has a direct ownership of 14 Million shares of IOBT, which is worth approximately $12.6 Million. The most recent transaction as insider was on Aug 09, 2023, when has been sold 7,901,234 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $15,012,344. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14M
0% 3M change
0% 12M change
Total Value Held $12.6 Million

Invest A/S Lundbeckfond Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
BUY
Grant, award, or other acquisition
$15,012,344 $1.9 p/Share
7,901,234 Added 36.16%
13,950,686 Common Stock
Nov 09 2021
BUY
Open market or private purchase
$29,999,998 $14.0 p/Share
2,142,857 Added 26.16%
6,049,452 Common Stock
Nov 09 2021
BUY
Conversion of derivative security
-
3,906,595 Added 50.0%
3,906,595 Common Stock

Also insider at

LXEO
Lexeo Therapeutics, Inc.
IAL

Invest A/S Lundbeckfond

Copenhagen, G7

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Track Activities on IOBT